Global Topical Antifungals Market Size Likely to Grow at a CAGR of 4.67% By 2035

Market Size and Growth

As per the topical antifungals market size analysis conducted by the CMI team, the topical antifungals market is expected to record a CAGR of 4.67% from 2026 to 2035. In 2026, the market size was USD 18.14 Billion. By 2035, the valuation is anticipated to reach USD 27.35 Billion.

Topical Antifungals Market Revenue and Trends

The topical antifungals market is expected to witness growth on a good note with rising demand for medical nail lacquers and allylamines, which do offer quicker fungicidal action in comparison with conventional azoles. The key dynamics include faster expansion of various e-pharmacy channels and integration of dermatological tools driven by AI for immediate self-diagnosis.

What are the Factors That Have a Significant Contribution to the Growth of the Topical Antifungals Market?

The topical antifungals market is growing as a greater number of people are contracting fungal infections. This is happening with those who have weak immune systems. As more people get ailments like diabetes, they are more likely to get onychomycosis and candidiasis that need to be treated with antifungals for a long time. The demand for antifungals is also increasing as people are taking better care of their skin and want to look good. They could easily buy topical antifungals over the counter so that they can treat themselves as soon as they notice something incorrect with their skin.

The other factor that matters is how fast drug delivery technologies are getting better. This is due to nanoparticles and medicated nail polish. These new things help solve the problem of the skin being a barrier. This means that the good stuff in these products like allylamines and azoles can get deeper into the skin and work longer. The internet is also playing a role over here. People can use their computers and phones to get help and buy what they need. This makes it easier for people to get what they need and have it delivered to their homes.

Segment Insights

By Product Type

Azoles dominate the market with over 40% of the market share. This is because they work well for common fungal and yeast infections, and people have been using them for a long time without many problems. They can be bought without a prescription as well (like Clotrimazole). On the other hand, allylamines such as Terbinafine are gaining popularity. This is because they actually kill the fungus; they do not just stop it from growing. This means that people get well faster and they are less likely to get sick again. Azoles are not as strong as allylamines.

By Formulation Type

Creams are the first choice for treating skin infections. They work well, as they have a balance of ingredients that help them get absorbed into the skin easily. This makes them great for covering areas and calming down irritated skin. On the other hand, lotions are expected to grow fast until 2035. This is because they are not as thick as creams and soak into the skin quickly. They are perfect for treating infections in areas with a lot of hair or on parts of the body. People are also preferring lotions, as they are not greasy and dry quickly. This makes it easy for people to get dressed anywhere, which is great for people who are always on the go and need to treat conditions like ringworm or skin discoloration.

By Indication

Dermatophyte infections, also known as tinea, are the common type of fungal infections and are widespread globally. Onychomycosis or nail fungus is witnessing the fastest CAGR. This is because a larger number of people have diabetes, which makes them more likely to get nail infections. New and better treatments for nail fungus are being developed, such as medicated nail polishes and creams that can penetrate into the nail. These new treatments are more effective as well as non-invasive.

By Type/Access

People usually buy over-the-counter medications for infections like athlete’s foot and ringworm, as they can easily figure out what is wrong with them, and these medications are cheap and easy to get at stores. They do not need to go to the doctor to get these medications. Over-the-counter medications make up a part of the market with over 50 percent of the sales. On the other hand, prescription medications are gaining popularity because some fungal infections are getting harder to treat with the medications that people can buy at stores. Some people have infections on their nails that are really hard to get rid of. These infections need prescription medications that are stronger and need to be given by a doctor. New prescription medications are being devised that can get rid of these hard to treat infections. For example – there are nail polishes and foams that can really help get rid of infections that over-the-counter medications cannot. These new medications are making the prescription part of the market grow fast. Fungal infections are a problem, and people are looking for new ways to treat them. Prescription medications like these ones are becoming more popular, as they can really help people get rid of their fungal infections.

By Distribution Channel

Retail pharmacies and drugstores lead the market with over 35 percent of the market share as they provide people with fast access to treatments for bad infections like athlete’s foot. They also have pharmacists whom people trust to help them pick the products. On the other hand, online pharmacies are witnessing the fastest growth rate as doctor talks and skin apps let people send pictures of their infections and let the right medicine be sent to their homes without having to go to a store. Retail pharmacies and drug stores are still popular. Online pharmacies are becoming more popular because they offer convenience and discretion that is important for people who want to treat infections like athlete’s foot at home.

Regional Insights

North America dominates the topical antifungals market due to advanced dermatological infrastructure, high healthcare spending, OTC availability of antifungal drugs through Johnson & Johnson and Bayer, an increasing number of consumers who are informed about health products, and FDA approval for the use of medicated nail lacquers that contain amorolfine hydrochloride and ciclopirox. The Asia Pacific topical antifungals market is expected to expand at the fastest CAGR during the forecast period. The Asia Pacific antifungals market is expected to expand at a CAGR of 10.2% during the forecast period as it is driven by a large population, tropical climates (causing susceptibility to fungal infections), and growth of e-pharmacies in countries such as China and India. In addition, the presence of local manufacturers who are able to produce generic azoles at a lower cost is adding to the revenue.

Report Scope

Recent Developments

• In September 2024, the European Medicines Agency reaffirmed that it had authorized VFEND (voriconazole) with the objective to treat serious fungal infections and invasive aspergillosis all over Europe, whereby it would be supporting continuous clinical usage of systemic antifungal therapy devised by Pfizer.

List of the prominent players in the Topical Antifungals Market:

• Bayer AG
• Pfizer Inc.
• Novartis AG
• GlaxoSmithKline (GSK)
• Others

The Topical Antifungals Market is segmented as follows:

By Product Type

• Azoles
• Allylamines
• Polyenes & Echinocandins

By Formulation Type

• Creams
• Ointments
• Lotions
• Sprays
• Powders

By Indication

• Dermatophyte Infections/Tinea
• Onychomycosis
• Candidiasis

By Type/Access

• OTC (Over-the-Counter)
• Prescription

By Distribution Channel

• Retail Pharmacies & Drug Stores
• Online Pharmacies
• Hospital Pharmacies

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America